PFE - Has a Bottom Been Reached?I've been sticking with Pfizer for far too long to abandon it. The dividends have continued to roll in and with a 7%+ payout rate, this one is bound to get some bids, sooner or later. I'm adding at this level.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.39 USD
8.02 B USD
63.63 B USD
5.67 B
About Pfizer
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
FIGI
BBG000BR2B91
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
$3.9 Billion At Support?Long term buy structure forming now.
Large volume sweeps and blocks are being made here. Very large trade at this level happened last week and I think this is going to explode in the coming weeks/months.
Target #1 - $35
Target #2 - $40
PFE eyes on $22.4x: Key hurdle to mark bottom IF there IS one ?PFE can't seem to dig a hole deep enough.
Trapped under a key resistance $22.43/49
Break and Retest could indicate bottomed.
PFE – Long Trade Setup !📈 🟢
Ticker: Pfizer, Inc. (NYSE: PFE)
Chart: 30-Min Timeframe
Pattern: Ascending triangle breakout continuation
🔹 Entry: $24.38 (breakout from consolidation + trendline support)
🔹 Stop-Loss: $24.01 (below ascending trendline)
🔹 Take Profits:
TP1: $24.89 – Gap-fill resistance zone
TP2: $25.55 – M
Pfizer Stock Chart Fibonacci Analysis 042925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 22.7/61.80%
Chart time frame:D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: C
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
Tensions in the Pharma Sector and Signs of U.S. StagflationBy Ion Jauregui – Analyst at ActivTrades
The U.S. biopharmaceutical industry may soon face significant regulatory changes. According to sector sources, the Trump administration is evaluating a proposal to tie U.S. drug prices to the lowest prices available in other developed countries. This initiati
PFEAt the current price, I'm looking for a retest toward the daily target zone located on the chart. On 3/21 PFE announced news about dropping the decision to move forward with the weight loss drug. Since then, price dropped down in spike like fashion. After the big volume spike, on that date, volume c
OptionsMastery: Looking like more downside on PFE!🔉Sound on!🔉
📣Make sure to watch fullscreen!📣
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!
The Collaborative Edge: Pfizer's Innovation Secret? Pfizer's success in the biopharmaceutical industry hinges on its internal capabilities and a strategic embrace of external collaboration. This proactive approach, spanning diverse technological frontiers, fuels innovation across its operations. From partnering with QuantumBasel and D-Wave to optimiz
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063Yield to maturity
6.24%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
6.13%
Maturity date
May 19, 2053
See all PFE bonds
Curated watchlists where PFE is featured.
Related stocks
Frequently Asked Questions
The current price of PFE is 23.97 USD — it has decreased by −0.96% in the past 24 hours. Watch Pfizer stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer stocks are traded under the ticker PFE.
PFE stock has risen by 4.07% compared to the previous week, the month change is a 0.12% rise, over the last year Pfizer has showed a −13.97% decrease.
We've gathered analysts' opinions on Pfizer future price: according to them, PFE price has a max estimate of 33.00 USD and a min estimate of 23.00 USD. Watch PFE chart and read a more detailed Pfizer stock forecast: see what analysts think of Pfizer and suggest that you do with its stocks.
PFE stock is 1.66% volatile and has beta coefficient of 0.32. Track Pfizer stock price on the chart and check out the list of the most volatile stocks — is Pfizer there?
Today Pfizer has the market capitalization of 137.25 B, it has increased by 2.31% over the last week.
Yes, you can track Pfizer financials in yearly and quarterly reports right on TradingView.
Pfizer is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are 0.92 USD per share, whereas the estimation was 0.67 USD resulting in a 38.23% surprise. The estimated earnings for the next quarter are 0.56 USD per share. See more details about Pfizer earnings.
Pfizer revenue for the last quarter amounts to 13.71 B USD, despite the estimated figure of 13.92 B USD. In the next quarter, revenue is expected to reach 13.43 B USD.
PFE net income for the last quarter is 2.97 B USD, while the quarter before that showed 403.00 M USD of net income which accounts for 636.23% change. Track more Pfizer financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was 0.43 USD. As of today, Dividend Yield (TTM)% is 6.98%. Tracking Pfizer dividends might help you take more informed decisions.
Pfizer dividend yield was 6.37% in 2024, and payout ratio reached 119.94%. The year before the numbers were 5.73% and 444.50% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 5, 2025, the company has 81 K employees. See our rating of the largest employees — is Pfizer on this list?
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer stock shows the sell signal. See more of Pfizer technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.